Access our on-demand webinar to learn about sequencing of the SARS-CoV-2 genome on the GenapSys™ platform
Dr. Saurabh Paliwal, Associate Director, Molecular Biology & NGS Applications at GenapSys shared:
- a truly decentralized and low cost NGS solution for surveillance and testing for the COVID-19 pandemic
- the platform's compatibility with diverse library preparation assays – from hybrid capture panels to multiplex PCR amplicon panels
- the platform's detection accuracy of SARS-CoV-2 variants – including a wide range of viral titers, even at low read coverages
If you have any questions regarding the GenapSys sequencing platform, please contact us at www.genapsys.com.